Hong Kong (1)

IDH Mutation (1)

PTEN Gene Inactivation (1)

Poly ADP Ribose Polymerase (PARP) Inhibitor (1)

Recurrent Glioblastoma (1)

Recurrent Glioma (1)

Recruiting (1)

phase 2 (1)

The University of Hong Kong (1)

talazoparib (1)

drug (1)

Other (1)

Interventional (1)

poly adp ribose polymerase (parp) inhibitor

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Aug 19, 2021